Are you looking for a stock?

Try one of these

U.S. News

Valeant Pharma is not investable, fund managers tell BNN
Many of Canada's top money managers are keeping their clients' cash away from Valeant Pharmaceuticals, recent BNN surveys reveal, but not due to the company's fight against allegations of accounting fraud.
Posted on 11-10-2015 at 6:04 PM
Obama administration rejects Keystone XL pipeline
U.S. President Barack Obama on Friday rejected TransCanada Corp’s $8-billion Keystone XL pipeline scheme to funnel Alberta oil sands crude to the gulf coast and world markets, handing environmentalists a huge albeit symbolic victory in the battle to cut greenhouse gas emissions.
Posted on 11-06-2015 at 11:19 AM
Valeant says Goldman sold 1.3 million shares backing loan to CEO
Goldman Sachs Group Inc. has sold 1.3 million shares it was holding as collateral for loans of about US$100-million to Valeant Pharmaceuticals International Inc. chief executive officer Michael Pearson.
Posted on 11-06-2015 at 9:31 AM
Robust U.S. jobs report bolsters December rate hike case
The solid employment and wage gains added to robust automobile sales in painting an upbeat picture of the U.S. economy at the start of the fourth quarter.
Posted on 11-06-2015 at 8:39 AM
Exclusive: Nobilis Health will identify short-seller in lawsuit
BNN has learned that Nobilis could file a lawsuit against what the company calls “market-manipulators” as early as Thursday morning.
Posted on 11-04-2015 at 12:49 PM
U.S. Senate panel probing Valeant, Turing over drug costs
A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical drug pricing, seeking documents from four drug makers including Valeant Pharmaceuticals and Turing Pharmaceuticals.
Posted on 11-04-2015 at 10:03 AM
U.S. calls TransCanada’s pause request on Keystone XL ‘unusual’
The day after TransCanada requested a pause in the U.S. presidential permitting process for its beleaguered Keystone XL project, the White House has signalled its displeasure.
Posted on 11-04-2015 at 7:32 AM
Valeant short-seller refrains from releasing new allegations
The short-seller who took aim at Valeant says the drugmaker is "toxic" and uninvestible. But Citron stopped short of delivering another bombshell, saying its work on the company is done.
Posted on 11-02-2015 at 11:01 AM

News by Sector

Today's Guests CTV Two CTV News CTV News Channel BNN - Business News Network CP24